Clinical Trial Update: A Study of Epoetin Beta (NeoRecormon) in Anemic Participants With Diabetes and Chronic Renal Failure Who Are Not on Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating epoetin beta (NeoRecormon) for anemia in participants with diabetes and chronic kidney disease not on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease
• Diabetes Mellitus

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED